Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Jul 1;89(13):5852–5856. doi: 10.1073/pnas.89.13.5852

Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.

M Z Atassi 1, K H Ruan 1, K Jinnai 1, M Oshima 1, T Ashizawa 1
PMCID: PMC49395  PMID: 1378618

Abstract

A synthetic peptide corresponding to a myasthenogenic region of Torpedo californica acetylcholine (AcCho) receptor (AcChoR) alpha subunit, AcChoR alpha-(125-148), was conjugated to monomethoxypolyethylene glycol (mPEG). Injection of mice with the mPEG-AcChoR alpha-(125-148) conjugate and subsequent immunization with whole Torpedo AcChoR suppressed the development of experimental autoimmune myasthenia gravis (EAMG) by electrophysiological criteria. In anti-AcChoR sera from these animals, the antibody response against unconjugated AcChoR alpha-(125-148) was decreased, while the antibody responses against whole AcChoR and other epitopes were not altered. There were no detectable changes in T-cell proliferation responses to AcChoR alpha-(125-148) or to whole AcChoR in these animals. Prior injections with a "nonsense" peptide-mPEG conjugate had no effect on responses to the subsequent immunization with whole Torpedo AcChoR. The results indicate that the mPEG-AcChoR alpha-(125-148) conjugate has epitope-specific tolerogenicity for antibody responses in EAMG and that the AcChoR alpha-subunit region comprising residues 125-148 plays an important pathophysiological role in EAMG. The epitope-directed tolerogenic conjugates may be useful for future immunotherapies of human myasthenia gravis. The strategy of specific suppression of the antibody response to a predetermined epitope by using a synthetic mPEG-peptide conjugate may prove useful in manipulation and suppression of unwanted immune responses such as autoimmunity and allergy.

Full text

PDF
5852

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abuchowski A., van Es T., Palczuk N. C., Davis F. F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem. 1977 Jun 10;252(11):3578–3581. [PubMed] [Google Scholar]
  2. Ashizawa T., Appel S. H. Immunopathologic events at the endplate in myasthenia gravis. Springer Semin Immunopathol. 1985;8(3):177–196. doi: 10.1007/BF00197295. [DOI] [PubMed] [Google Scholar]
  3. Atassi M. Z., Manshouri T. Synthesis of tolerogenic monomethoxypolyethylene glycol and polyvinyl alcohol conjugates of peptides. J Protein Chem. 1991 Dec;10(6):623–627. doi: 10.1007/BF01025714. [DOI] [PubMed] [Google Scholar]
  4. Atassi M. Z., Saplin B. J. Immunochemistry of sperm whale myoglobin. I. The specific interaction of some tryptic peptides and of peptides containing all the reactive regions of the antigen. Biochemistry. 1968 Feb;7(2):688–698. doi: 10.1021/bi00842a026. [DOI] [PubMed] [Google Scholar]
  5. Froehner S. C., Rafto S. Comparison of the subunits of Torpedo californica acetylcholine receptor by peptide mapping. Biochemistry. 1979 Jan 23;18(2):301–307. doi: 10.1021/bi00569a011. [DOI] [PubMed] [Google Scholar]
  6. Holford-Strevens V., Jackson C. J., Charlton J., Akiyama K. A., Lang G. M., Carter B. G., Sehon A. H. Induction of in vivo helper activity for murine antibody responses by macrophages pulsed with ovalbumin-monomethoxypolyethylene glycol (OA-mPEG) conjugates. Cell Immunol. 1987 Feb;104(2):245–254. doi: 10.1016/0008-8749(87)90027-x. [DOI] [PubMed] [Google Scholar]
  7. Jackson C. J., Charlton J. L., Kuzminski K., Lang G. M., Sehon A. H. Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent. Anal Biochem. 1987 Aug 15;165(1):114–127. doi: 10.1016/0003-2697(87)90208-9. [DOI] [PubMed] [Google Scholar]
  8. King T. P., Kochoumian L., Chiorazzi N. Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D-lysine. J Exp Med. 1979 Feb 1;149(2):424–435. doi: 10.1084/jem.149.2.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. King T. P., Kochoumian L., Lichtenstein L. M. Preparation and immunochemical properties of methoxypolyethylene glycol-coupled and N-carboxymethylated derivatives of ragweed pollen allergen, antigen E. Arch Biochem Biophys. 1977 Jan 30;178(2):442–450. doi: 10.1016/0003-9861(77)90214-4. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lee W. Y., Sehon A. H. Abrogation of reaginic antibodies with modified allergens. Nature. 1977 Jun 16;267(5612):618–619. doi: 10.1038/267618a0. [DOI] [PubMed] [Google Scholar]
  12. Lee W. Y., Sehon A. H., Akerblom E. Suppression of reaginic antibodies with modified allergens. IV. Induction of suppressor T cells by conjugates of polyethylene glycol (PEG) and monomethoxy PEG with ovalbumin. Int Arch Allergy Appl Immunol. 1981;64(1):100–114. [PubMed] [Google Scholar]
  13. Lee W. Y., Sehon A. H. Suppression of reaginic antibodies with modified allergens. I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol. Int Arch Allergy Appl Immunol. 1978;56(2):159–170. doi: 10.1159/000232019. [DOI] [PubMed] [Google Scholar]
  14. Lennon V. A., McCormick D. J., Lambert E. H., Griesmann G. E., Atassi M. Z. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8805–8809. doi: 10.1073/pnas.82.24.8805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McCormick D. J., Atassi M. Z. Localization and synthesis of the acetylcholine-binding site in the alpha-chain of the Torpedo californica acetylcholine receptor. Biochem J. 1984 Dec 15;224(3):995–1000. doi: 10.1042/bj2240995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mokashi S., Holford-Strevens V., Sterrantino G., Jackson C. J., Sehon A. H. Down-regulation of secondary in vitro antibody responses by suppressor T cells of mice treated with a tolerogenic conjugate of ovalbumin and monomethoxypolyethylene glycol, OVA(mPEG)13. Immunol Lett. 1989 Dec;23(2):95–102. doi: 10.1016/0165-2478(89)90119-3. [DOI] [PubMed] [Google Scholar]
  17. Mosbech H., Dirksen A., Dreborg S., Frølund L., Heinig J. H., Svendsen U. G., Søborg M., Taudorf E., Weeke B. Hyposensitization in asthmatics with mPEG-modified and unmodified house dust mite extract. IV. Occurrence and prediction of side effects. Allergy. 1990 Feb;45(2):142–150. doi: 10.1111/j.1398-9995.1990.tb00472.x. [DOI] [PubMed] [Google Scholar]
  18. Mulac-Jericevic B., Atassi M. Z. Profile of the alpha-bungarotoxin-binding regions on the extracellular part of the alpha-chain of Torpedo californica acetylcholine receptor. Biochem J. 1987 Dec 15;248(3):847–852. doi: 10.1042/bj2480847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mulac-Jericević B., Kurisaki J., Atassi M. Z. Profile of the continuous antigenic regions on the extracellular part of the alpha chain of an acetylcholine receptor. Proc Natl Acad Sci U S A. 1987 Jun;84(11):3633–3637. doi: 10.1073/pnas.84.11.3633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Müller U., Rabson A. R., Bischof M., Lomnitzer R., Dreborg S., Lanner A. A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical results. J Allergy Clin Immunol. 1987 Sep;80(3 Pt 1):252–261. doi: 10.1016/0091-6749(87)90027-3. [DOI] [PubMed] [Google Scholar]
  21. Noda M., Takahashi H., Tanabe T., Toyosato M., Furutani Y., Hirose T., Asai M., Inayama S., Miyata T., Numa S. Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature. 1982 Oct 28;299(5886):793–797. doi: 10.1038/299793a0. [DOI] [PubMed] [Google Scholar]
  22. Nordvall S. L., Uhlin T., Ohman S., Björkander J., Malling H. J., Weeke B., Dreborg S., Lanner A., Einarsson R. IgG and IgE antibody patterns after immunotherapy with monomethoxy polyethyleneglycol modified honey bee venom. Allergy. 1986 Feb;41(2):89–94. doi: 10.1111/j.1398-9995.1986.tb00283.x. [DOI] [PubMed] [Google Scholar]
  23. Pachner A. R., Kantor F. S., Mulac-Jericevic B., Atassi M. Z. An immunodominant site of acetylcholine receptor in experimental myasthenia mapped with T lymphocyte clones and synthetic peptides. Immunol Lett. 1989 Feb;20(3):199–204. doi: 10.1016/0165-2478(89)90080-1. [DOI] [PubMed] [Google Scholar]
  24. Rotman B., Papermaster B. W. Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci U S A. 1966 Jan;55(1):134–141. doi: 10.1073/pnas.55.1.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruan K. H., Spurlino J., Quiocho F. A., Atassi M. Z. Acetylcholine receptor-alpha-bungarotoxin interactions: determination of the region-to-region contacts by peptide-peptide interactions and molecular modeling of the receptor cavity. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6156–6160. doi: 10.1073/pnas.87.16.6156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ruan K. H., Stiles B. G., Atassi M. Z. The short-neurotoxin-binding regions on the alpha-chain of human and Torpedo californica acetylcholine receptors. Biochem J. 1991 Mar 15;274(Pt 3):849–854. doi: 10.1042/bj2740849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sehon A. H. Modulation of antibody responses by conjugates of antigens with monomethoxypolyethylene glycol. Adv Exp Med Biol. 1989;251:341–351. doi: 10.1007/978-1-4757-2046-4_30. [DOI] [PubMed] [Google Scholar]
  28. Sehon A. H. Suppressor T cells induced in vivo by tolerogenic conjugates of a given antigen and monomethoxypolyethylene glycol downregulate antibody formation also to a second antigen, if the latter is presented as a covalent adduct with the former. Adv Exp Med Biol. 1991;303:199–206. doi: 10.1007/978-1-4684-6000-1_21. [DOI] [PubMed] [Google Scholar]
  29. Wie S. I., Wie C. W., Lee W. Y., Filion L. G., Sehon A. H., Akerblom E. Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method. Int Arch Allergy Appl Immunol. 1981;64(1):84–99. [PubMed] [Google Scholar]
  30. Yokoi T., Mulac-Jericević B., Kurisaki J., Atassi M. Z. T lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor. Eur J Immunol. 1987 Dec;17(12):1697–1702. doi: 10.1002/eji.1830171204. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES